Topiroxostat: Difference between revisions

Topiroxostat
INN
Drug class
Routes of administration
Pregnancy category
Bioavailability
Metabolism
Elimination half-life
Excretion
Legal status
CAS Number
PubChem
DrugBank
ChemSpider
KEGG

Newer edit →

Revision as of 12:00, 9 February 2025

A xanthine oxidase inhibitor used to treat hyperuricemia

Topiroxostat is a medication used primarily for the treatment of hyperuricemia in patients with gout. It functions as a xanthine oxidase inhibitor, which helps to reduce the production of uric acid in the body.

Mechanism of Action

Topiroxostat works by inhibiting the activity of xanthine oxidase, an enzyme responsible for the conversion of hypoxanthine to xanthine and subsequently to uric acid. By blocking this enzyme, topiroxostat decreases the production of uric acid, thereby lowering its levels in the blood.

Clinical Use

Topiroxostat is prescribed for patients with hyperuricemia associated with gout. It is particularly useful for individuals who have not responded adequately to other treatments or who have contraindications to other medications.

Side Effects

Common side effects of topiroxostat include liver function test abnormalities, nausea, and rash. Patients are advised to undergo regular monitoring of liver function during treatment.

Pharmacokinetics

Topiroxostat is administered orally and is absorbed in the gastrointestinal tract. It is metabolized in the liver and excreted primarily through the kidneys.

Related Pages

References

Kamatani, N., et al. (2014). "Efficacy and safety of topiroxostat, a novel xanthine oxidase inhibitor, in Japanese hyperuricemic patients with or without gout: a 12-week, multicenter, double-blind, placebo-controlled, parallel-group study." Clinical Therapeutics, 36(10), 1562-1576.
Yamanaka, H., et al. (2017). "Topiroxostat for the treatment of hyperuricemia in patients with gout: a phase 3, multicenter, randomized, double-blind, placebo-controlled study." Arthritis Research & Therapy, 19(1), 1-10.

@@ Line 1: / Line 1: @@
-'''Topiroxostat''' is a pharmaceutical drug used primarily in the treatment of [[gout]]. It is a [[xanthine oxidase inhibitor]], a type of medication that works by decreasing the amount of [[uric acid]] produced in the body. Topiroxostat is marketed under the brand name Topiloric in Japan by [[Sanwa Kagaku Kenkyusho]].
+{{Short description|A xanthine oxidase inhibitor used to treat hyperuricemia}}
+{{Drugbox
+| verifiedfields = changed
+| verifiedrevid = 477002123
+| image = Topiroxostat.svg
+| width = 200px
+}}
-== Mechanism of Action ==
+'''Topiroxostat''' is a medication used primarily for the treatment of [[hyperuricemia]] in patients with [[gout]]. It functions as a [[xanthine oxidase]] inhibitor, which helps to reduce the production of [[uric acid]] in the body.
-Topiroxostat inhibits the enzyme [[xanthine oxidase]], which is involved in the production of uric acid in the body. By inhibiting this enzyme, topiroxostat reduces the levels of uric acid, thereby preventing the formation of uric acid crystals that cause gout.
-== Uses ==
+==Mechanism of Action==
-Topiroxostat is used in the treatment of chronic [[gout]], a type of inflammatory arthritis caused by high levels of uric acid in the blood. It is also used to treat [[hyperuricemia]], a condition characterized by an excess of uric acid in the blood.
+Topiroxostat works by inhibiting the activity of xanthine oxidase, an enzyme responsible for the conversion of [[hypoxanthine]] to [[xanthine]] and subsequently to uric acid. By blocking this enzyme, topiroxostat decreases the production of uric acid, thereby lowering its levels in the blood.
-== Side Effects ==
+==Clinical Use==
-Common side effects of topiroxostat include liver function abnormalities, kidney function abnormalities, and gastrointestinal disorders. Rare but serious side effects include severe skin reactions and hypersensitivity reactions.
+Topiroxostat is prescribed for patients with hyperuricemia associated with gout. It is particularly useful for individuals who have not responded adequately to other treatments or who have contraindications to other medications.
-== Contraindications ==
+==Side Effects==
-Topiroxostat is contraindicated in patients with severe renal impairment or end-stage renal disease. It is also contraindicated in patients with a history of hypersensitivity to topiroxostat or any of its components.
+Common side effects of topiroxostat include [[liver function test]] abnormalities, [[nausea]], and [[rash]]. Patients are advised to undergo regular monitoring of liver function during treatment.
-== Interactions ==
+==Pharmacokinetics==
-Topiroxostat may interact with other medications, including other xanthine oxidase inhibitors, diuretics, and certain types of cancer medications. Patients should inform their healthcare provider of all medications they are currently taking before starting treatment with topiroxostat.
+Topiroxostat is administered orally and is absorbed in the gastrointestinal tract. It is metabolized in the liver and excreted primarily through the kidneys.
-== See Also ==
+==Related Pages==
 * [[Gout]]
+* [[Hyperuricemia]]
 * [[Xanthine oxidase inhibitor]]
-* [[Uric acid]]
-* [[Hyperuricemia]]
-[[Category:Drugs]]
+==References==
-[[Category:Gout]]
+* Kamatani, N., et al. (2014). "Efficacy and safety of topiroxostat, a novel xanthine oxidase inhibitor, in Japanese hyperuricemic patients with or without gout: a 12-week, multicenter, double-blind, placebo-controlled, parallel-group study." ''Clinical Therapeutics'', 36(10), 1562-1576.
+* Yamanaka, H., et al. (2017). "Topiroxostat for the treatment of hyperuricemia in patients with gout: a phase 3, multicenter, randomized, double-blind, placebo-controlled study." ''Arthritis Research & Therapy'', 19(1), 1-10.
+[[Category:Drugs used in gout]]
 [[Category:Xanthine oxidase inhibitors]]
-[[Category:Uric acid]]
-{{stub}}